Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Shimada

Showing results (121-130 of 365) with videos related to

Pageof 37
Sort By:
Cancer Research|June 3, 2005
Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidyTakeshi Tomonaga, Kazuyuki Matsushita, Masumi Ishibashi, et al.
Oncology Reports|March 10, 2006
Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiationHiroyuki Kitabayashi, Hideaki Shimada, Shigeru Yamada, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
Serum p53 antibody as a diagnostic marker of high-risk endometrial cancerKoji Yamazawa, Hideaki Shimada, Makiko Hirai, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 27, 2011
Possible mechanism of superoxide formation through redox cycling of plumbagin in pig heartHideaki Shimada, Yusuke Yamaoka, Reiko Morita, et al.
BMC Cancer|March 25, 2017
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelinGuntulu Ak, Yuji Tada, Hideaki Shimada, et al.
Annals of Gastroenterological Surgery|March 30, 2019
Diagnostic impact of high serum midkine level in patients with gastric cancerMasaaki Ito, Yoko Oshima, Satoshi Yajima, et al.
Surgery Today|March 8, 2021
Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancerJin Moriyama, Yoko Oshima, Tatsuki Nanami, et al.
Surgery Today|February 1, 2003
Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycinShinichi Miyazaki, Yoshio Gunji, Hisahiro Matsubara, et al.
World Journal of Gastroenterology|April 26, 2014
Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapyKazuyuki Matsushita, Hideaki Shimada, Yasuji Ueda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 20, 2019
The effectiveness of serum midkine in detecting esophageal squamous cell carcinomaFumiaki Shiratori, Masaaki Ito, Satoshi Yajima, et al.
Pageof 37

Showing results (121-130 of 365) with videos related to

Sort By:
Pageof 37
Cancer Research|June 3, 2005
Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidyTakeshi Tomonaga, Kazuyuki Matsushita, Masumi Ishibashi, et al.
Oncology Reports|March 10, 2006
Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiationHiroyuki Kitabayashi, Hideaki Shimada, Shigeru Yamada, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
Serum p53 antibody as a diagnostic marker of high-risk endometrial cancerKoji Yamazawa, Hideaki Shimada, Makiko Hirai, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 27, 2011
Possible mechanism of superoxide formation through redox cycling of plumbagin in pig heartHideaki Shimada, Yusuke Yamaoka, Reiko Morita, et al.
BMC Cancer|March 25, 2017
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelinGuntulu Ak, Yuji Tada, Hideaki Shimada, et al.
Annals of Gastroenterological Surgery|March 30, 2019
Diagnostic impact of high serum midkine level in patients with gastric cancerMasaaki Ito, Yoko Oshima, Satoshi Yajima, et al.
Surgery Today|March 8, 2021
Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancerJin Moriyama, Yoko Oshima, Tatsuki Nanami, et al.
Surgery Today|February 1, 2003
Possible involvement of antitumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycinShinichi Miyazaki, Yoshio Gunji, Hisahiro Matsubara, et al.
World Journal of Gastroenterology|April 26, 2014
Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapyKazuyuki Matsushita, Hideaki Shimada, Yasuji Ueda, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 20, 2019
The effectiveness of serum midkine in detecting esophageal squamous cell carcinomaFumiaki Shiratori, Masaaki Ito, Satoshi Yajima, et al.
Pageof 37